SOD1 and amyotrophic lateral sclerosis: Targeted metabolomics identified elevated levels of the arachidonic acid pathway and reduction of arachidonic acid reverse ALS phenotypes in human and Drosophila spinal motor neurons and SOD1 mouse models [188].